Fermenta Biotec.

37
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID: FERMENTA
  • BSEID: 506414
INR
450.85
-5.4 (-1.18%)
BSENSE

Jul 29, 12:49 PM

BSE+NSE Vol: 42.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
525.00
469.00
335.00
349.00
398.00
377.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
1.00
Net Sales
525.00
469.00
335.00
349.00
398.00
375.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-31.00
26.00
22.00
6.00
-28.00
Raw Materials Consumed
192.00
189.00
104.00
131.00
146.00
163.00
Power & Fuel Cost
29.00
27.00
19.00
18.00
20.00
14.00
Employee Cost
82.00
65.00
58.00
57.00
62.00
58.00
Operating Expenses
48.00
48.00
50.00
44.00
45.00
37.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
23.00
17.00
11.00
13.00
17.00
19.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
9.00
11.00
8.00
10.00
7.00
9.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
424.00
358.00
307.00
331.00
336.00
293.00
Operating Profit (PBDIT) excl Other Income
100.00
110.00
27.00
18.00
62.00
82.00
Other Income
22.00
11.00
11.00
8.00
8.00
8.00
Operating Profit (PBDIT)
123.00
122.00
39.00
26.00
70.00
90.00
Interest
12.00
14.00
17.00
21.00
17.00
19.00
Profit before Depriciation and Tax
110.00
107.00
22.00
5.00
52.00
71.00
Depreciation
21.00
24.00
24.00
28.00
25.00
20.00
Profit Before Taxation & Exceptional Items
88.00
83.00
-2.00
-22.00
26.00
51.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
95.00
83.00
-9.00
-51.00
26.00
51.00
Provision for Tax
25.00
6.00
14.00
1.00
11.00
9.00
Profit After Tax
70.00
76.00
-24.00
-53.00
15.00
42.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
325.00
252.00
279.00
326.00
318.00
272.00
Profit Available for appropriations
397.00
329.00
256.00
275.00
333.00
318.00
Appropriations
397.00
329.00
256.00
275.00
333.00
318.00
Equity Dividend (%)
75.00%
50.00%
25.00%
25.00%
25.00%
50.00%
Earnings Per Share
24.70
26.35
-7.99
-17.70
5.35
15.77
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 11.92% vs 39.87% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -8.64% vs 296.21% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -15.01% vs -14.53% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -8.05% vs 418.23% in Mar 2025

Compare Profit and Loss Results of Fermenta Biotec.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
525.00
0
525.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
525.00
0
525.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
192.00
0
192.00
0%
Power & Fuel Cost
29.00
0
29.00
0%
Employee Cost
82.00
0
82.00
0%
Operating Expenses
48.00
0
48.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
23.00
0
23.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
9.00
0
9.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
424.00
0
424.00
0%
Operating Profit (PBDIT) excl Other Income
100.00
0.00
100.00
0%
Other Income
22.00
0
22.00
0%
Operating Profit (PBDIT)
123.00
0
123.00
0%
Interest
12.00
0
12.00
0%
Profit before Depriciation and Tax
110.00
0
110.00
0%
Depreciation
21.00
0
21.00
0%
Profit Before Taxation & Exceptional Items
88.00
0
88.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
95.00
0
95.00
0%
Provision for Tax
25.00
0
25.00
0%
Profit After Tax
70.00
0
70.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
325.00
0
325.00
0%
Profit Available for appropriations
397.00
0
397.00
0%
Appropriations
397.00
0
397.00
0%
Equity Dividend (%)
75%
0%
75.00
Earnings Per Share
24.7
0
24.70
0%
Profit And Loss - Net Sales
Net Sales 525.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.92% vs 39.87% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 100.95 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -8.64% vs 296.21% in Mar 2025

Profit And Loss - Interest
Interest 12.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -15.01% vs -14.53% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 70.25 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -8.05% vs 418.23% in Mar 2025